Assignee
LA JOLLA INST FOR IMMUNOLOGY
US·1 granted patent·38 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
39 records- 0164US2024294900A1Common Cold Coronavirus T Cell Epitopes, Methods and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2024·Application pending·0 cites
- 0260US2026041755A1Alphavirus t cell epitopes, megapools and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2025·Application pending·0 cites
- 0358US2025341513A1Bordetella T Cells Epitopes, Megapools and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0457US2022325261A1Ptprs and proteoglycans in autoimmune diseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0556US2026000710A1Novel Treatments for Cardiovascular Related DiseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0654US2023381231A1Compositions for cancer treatment and methods and uses for cancer treatment and prognosisLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0754US2024156939A1Flavivirus peptide sequences, epitopes, and methods and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0852US2025381265A1Coronavirus Spike Glycoprotein With Improved Expression and StabilityLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0948US2023159649A1Methods and combinations for dual targeting of tnf family membersLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1048US2025231185A1Coronavirus T Cell Epitopes, Megapools and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1147US2023042198A1Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate ConditionsLA JOLLA INST FOR IMMUNOLOGY·Filed 2020·Application pending·0 cites
- 1247US2024425550A1Engineered rabies virus glycoprotein, compositions, and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1347US2023372394A1Batf and irf4 in t cells and cancer immunotherapyLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1446US2025332249A1Cytomegalovirus t cell epitopes and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1546US2024409587A1Coronavirus T Cell Epitopes and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1646US2024263237A1T cell transcriptomic profiles in parkinson's disease, and methods and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 1746US2025382353A1Anti-sars-cov2 spike (s) antibodies and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 1844US2024239844A1Combinations of viral proteins, peptide sequences, epitopes, and methods and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1943US2024400620A1Compositions Containing Coronavirus Proteins and EpitopesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 2043US2023293630A1Coronavirus T Cell Epitopes and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 2143US2021393740A1Ptprs and proteoglycans in rheumatoid arthritisLA JOLLA INST FOR IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 2242US2025320278A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 2342US2023399402A1Hla class ii-restricted tcrs against the kras g12>v activating mutationLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 2442US2023149526A1Combinations of flavivirus proteins, peptide sequences, epitopes, and methods and uses thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 2542US2023310568A1Engineered arenavirus glycoprotein compositions and methods of use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 2641US2024301037A1Chimeric anti-coronavirus spike protein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 2741US2025034213A1Engineered arenavirus glycoprotein compositions, methods and use thereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 2841US2026077032A1KARI NanoparticleLA JOLLA INST FOR IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 2940US2023204579A1Immune Cell Biomarkers of Cardiovascular DiseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 3040US2023391855A1Chimeric anti-sars-cov2 nucleoprotein antibodiesLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 3139US12427195B1Methods of neoantigen identificationLA JOLLA INST FOR IMMUNOLOGY·Filed 2020·Granted Sep 30, 2025·0 cites·10 claims
- 3239US2023293673A1Methods for treating and preventing cytomegalovirus infectionLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 3336US2024277716A1Suppressive T Cell Populations and Methods of Cancer ImmunotherapyLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 3436US2025304692A1Methods for modulating an immune response to cancer or tumor cellsLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 3531US2023417747A1Methods and compositions for diagnosing and treating virally-associated diseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 3630US2023398204A1Coronavirus Spike Glycoprotein With Improved Expression and StabilityLA JOLLA INST FOR IMMUNOLOGY·Filed 2020·Application pending·0 cites
- 3728US2023273205A1Methods and Compositions for Diagnosing and Treating CancerLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 3827US2022033464A1Methods and compositons for modulations of immune responseLA JOLLA INST FOR IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 3926US2023194524A1Stem Cell Memory T Cells, Methods and Uses for Modulating Inflammatory Responses, and Diagnosing and Treating Adverse Cardiovascular Events and DiseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LA JOLLA INST FOR IMMUNOLOGY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →